Ultimately, we performed a LDH assay and phenotypical and functional immune assays to evaluate the recombinant LAV-BPIFB4 (rhLAV-BPIFB4) ability in counteracting the lysate-induced cytotoxicity and counterbalancing the pro-inflammatory reaction following the infection. Here, BPIFB4 is linked to infection.